Microneedle Drug Delivery Systems Industry Overview
The global microneedle drug delivery systems market size was valued at USD 5.57 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.3% from 2021 to 2028.
There is a growing demand for microneedle drug delivery systems owing to the availability of safer alternatives to the conventional hypodermic injection, which is minimally invasive and enables pain-free administration. The current global scenario, where the COVID-19 vaccine is in high demand, is expected to offer growth opportunities for microneedles. In addition, the increasing cases of diabetes are expected to boost the market growth. For instance, as per the WHO, diabetes affected around 422 million individuals worldwide in 2014 from 108 million in 1980.
Microneedle drug delivery systems are more beneficial than conventional hypodermal injections because of advantages such as the quicker onset of action, increased permeability and efficacy, better patient compliance, and self-administration. Apart from improving therapeutic benefits, microneedles provide very precise and consistent results with low inter-subject variability in bioavailability.
Gather more insights about the market drivers, restrains and growth of the Global Microneedle Drug Delivery Systems Market
The use of microneedle drug delivery systems has extended its applications to many fields, such as vaccine administration, hormonal delivery, cancer therapy, pain management, and even cosmetics. Many microneedle products have entered the market in recent years. However, further research is needed to address various challenges before microneedles can be successfully introduced into the market. For instance, using 3D printed hybrid microneedle arrays, Carnegie Mellon University is developing a COVID-19 vaccine injection approach (Hybrid-MNA). Not only does the Hybrid-MNA technique allow for lesser doses, but it is also painless and has the potential for self-administration. These technologies will allow microneedles to be manufactured at a lower cost, thereby fostering the market growth.
There are chances of irritation or allergies to sensitive skin. As the needles are small and thin in comparison to the thickness of hair, microneedle tips might break, causing complications if they remain inside the skin. This necessitates the need for highly skilled and qualified medical practitioners. Furthermore, there are a limited number of products permitted by regulatory agencies across the world, which may limit the product's consistency and efficacy.
As a result of the COVID-19 pandemic, the healthcare system has witnessed enormous challenges. All outpatient treatments were limited or canceled during the COVID-19 pandemic to lessen the risk of viral transmission as most chronic pain therapies were regarded as non-urgent. COVID-19, on the other hand, is thought to be a springboard that is anticipated to dramatically increase patient footfall post-pandemic. Since then, demand for COVID-19 vaccines is expected to increase, and the market for microneedle drug delivery systems is estimated to expand more quickly as these systems are non-invasive and painless.
Browse through Grand View Research's Medical Devices Industry Research Reports
- Sports Mouthguard Market: The global sports mouthguard market size was valued at USD 3.7 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.9% from 2022 to 2030.
- Ocular Adhesives And Sealants Market: The global ocular adhesives and sealants market size was valued at USD 136.7 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.28% from 2022 to 2030.
Microneedle Drug Delivery Systems Market Segmentation
Grand View Research has segmented the global microneedle drug delivery systems market based on type, material, application, and region:
Microneedle Drug Delivery Systems Type Outlook (Revenue, USD Million, 2016 - 2028)
- Solid
- Hollow
- Dissolving
- Coated
- Others
Microneedle Drug Delivery Systems Material Outlook (Revenue, USD Million, 2016 - 2028)
- Silicon
- Metal
- Polymer
- Others
Microneedle Drug Delivery Systems Application Outlook (Revenue, USD Million, 2016 - 2028)
- Dermatology
- Drug Delivery
- Pain Management
- Cancer Therapy
- Vaccine Delivery
- Others
Microneedle Drug Delivery Systems Regional Outlook (Revenue, USD Million, 2016 - 2028)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Market Share Insights
- June 2021: Nanopass Technologies announced that its MicronJet, a microneedle-based technology for intradermal drug delivery, has received FDA clearance and CE marking. The device is designed for intradermal injections of any substance or medication, which has been approved for this method of administration.
Key Companies profiled:
Some prominent players in the global microneedle drug delivery systems market include:
- Raphas
- Novartis International AG
- Becton Dickinson and Company
- B. Braun
- Nanopass Technologies Limited
- Termo
- Smiths Medical
- Cardinal Health
- 3M
Order a free sample PDF of the Microneedle Drug Delivery Systems Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
